PTHrP is the principal factor in cancer-induced bone disease and is responsible for 80% of humoral hypercalcemia of malignancy and localized osteolysis associated with metastatic cancer; however, it was effectively excluded as the culprit in this case [5]. This evidence concerns the gene PTHLH and cancer.